These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

567 related articles for article (PubMed ID: 17504874)

  • 1. Three-dimensional radiobiologic dosimetry: application of radiobiologic modeling to patient-specific 3-dimensional imaging-based internal dosimetry.
    Prideaux AR; Song H; Hobbs RF; He B; Frey EC; Ladenson PW; Wahl RL; Sgouros G
    J Nucl Med; 2007 Jun; 48(6):1008-16. PubMed ID: 17504874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lung dosimetry for radioiodine treatment planning in the case of diffuse lung metastases.
    Song H; He B; Prideaux A; Du Y; Frey E; Kasecamp W; Ladenson PW; Wahl RL; Sgouros G
    J Nucl Med; 2006 Dec; 47(12):1985-94. PubMed ID: 17138741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accurate dosimetry in 131I radionuclide therapy using patient-specific, 3-dimensional methods for SPECT reconstruction and absorbed dose calculation.
    Dewaraja YK; Wilderman SJ; Ljungberg M; Koral KF; Zasadny K; Kaminiski MS
    J Nucl Med; 2005 May; 46(5):840-9. PubMed ID: 15872359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient-specific dosimetry for 131I thyroid cancer therapy using 124I PET and 3-dimensional-internal dosimetry (3D-ID) software.
    Sgouros G; Kolbert KS; Sheikh A; Pentlow KS; Mun EF; Barth A; Robbins RJ; Larson SM
    J Nucl Med; 2004 Aug; 45(8):1366-72. PubMed ID: 15299063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 3D calculation of absorbed dose for 131I-targeted radiotherapy: a Monte Carlo study.
    Saeedzadeh E; Sarkar S; Abbaspour Tehrani-Fard A; Ay MR; Khosravi HR; Loudos G
    Radiat Prot Dosimetry; 2012 Jul; 150(3):298-305. PubMed ID: 22069233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implementation and evaluation of patient-specific three-dimensional internal dosimetry.
    Kolbert KS; Sgouros G; Scott AM; Bronstein JE; Malane RA; Zhang J; Kalaigian H; McNamara S; Schwartz L; Larson SM
    J Nucl Med; 1997 Feb; 38(2):301-8. PubMed ID: 9025759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methodology to incorporate biologically effective dose and equivalent uniform dose in patient-specific 3-dimensional dosimetry for non-Hodgkin lymphoma patients targeted with 131I-tositumomab therapy.
    Amro H; Wilderman SJ; Dewaraja YK; Roberson PL
    J Nucl Med; 2010 Apr; 51(4):654-9. PubMed ID: 20237032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lung toxicity in radioiodine therapy of thyroid carcinoma: development of a dose-rate method and dosimetric implications of the 80-mCi rule.
    Sgouros G; Song H; Ladenson PW; Wahl RL
    J Nucl Med; 2006 Dec; 47(12):1977-84. PubMed ID: 17138740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 131I-tositumomab radioimmunotherapy: initial tumor dose-response results using 3-dimensional dosimetry including radiobiologic modeling.
    Dewaraja YK; Schipper MJ; Roberson PL; Wilderman SJ; Amro H; Regan DD; Koral KF; Kaminski MS; Avram AM
    J Nucl Med; 2010 Jul; 51(7):1155-62. PubMed ID: 20554734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Voxel-Level Dosimetry for Combined Iodine 131 Radiopharmaceutical Therapy and External Beam Radiation Therapy Treatment Paradigms for Head and Neck Cancer.
    Adam DP; Grudzinski JJ; Marsh IR; Hill PM; Cho SY; Bradshaw TJ; Longcor J; Burr A; Bruce JY; Harari PM; Bednarz BP
    Int J Radiat Oncol Biol Phys; 2024 Jul; 119(4):1275-1284. PubMed ID: 38367914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Three-dimensional personalized Monte Carlo dosimetry in 90Y resin microspheres therapy of hepatic metastases: nontumoral liver and lungs radiation protection considerations and treatment planning optimization.
    Petitguillaume A; Bernardini M; Hadid L; de Labriolle-Vaylet C; Franck D; Desbrée A
    J Nucl Med; 2014 Mar; 55(3):405-13. PubMed ID: 24504053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of image registration on 3D absorbed dose calculations in
    Grassi E; Fioroni F; Berenato S; Patterson N; Ferri V; Braglia L; Filice A; Versari A; Iori M; Spezi E
    Phys Med; 2018 Jan; 45():177-185. PubMed ID: 29472084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patient-specific, 3-dimensional dosimetry in non-Hodgkin's lymphoma patients treated with 131I-anti-B1 antibody: assessment of tumor dose-response.
    Sgouros G; Squeri S; Ballangrud AM; Kolbert KS; Teitcher JB; Panageas KS; Finn RD; Divgi CR; Larson SM; Zelenetz AD
    J Nucl Med; 2003 Feb; 44(2):260-8. PubMed ID: 12571219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A pilot study on the feasibility of real-time calculation of three-dimensional dose distribution for (153)Sm-EDTMP radionuclide therapy based on the voxel S-values.
    Feng G; Lixin C; Xiaowei L; Tsao SY; Weiguang Z; Wei F
    Cancer Biother Radiopharm; 2010 Jun; 25(3):345-52. PubMed ID: 20578840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Initial results for Hybrid SPECT--conjugate-view tumor dosimetry in 131I-anti-B1 antibody therapy of previously untreated patients with lymphoma.
    Koral KF; Dewaraja Y; Li J; Barrett CL; Regan DD; Zasadny KR; Rommelfanger SG; Francis IR; Kaminski MS; Wahl RL
    J Nucl Med; 2000 Sep; 41(9):1579-86. PubMed ID: 10994741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patient dosimetry in nuclear medicine.
    Mattsson S
    Radiat Prot Dosimetry; 2015 Jul; 165(1-4):416-23. PubMed ID: 25821210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Strengths and Weaknesses of a Planar Whole-Body Method of (153)Sm Dosimetry for Patients with Metastatic Osteosarcoma and Comparison with Three-Dimensional Dosimetry.
    Plyku D; Loeb DM; Prideaux AR; Baechler S; Wahl RL; Sgouros G; Hobbs RF
    Cancer Biother Radiopharm; 2015 Nov; 30(9):369-79. PubMed ID: 26560193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic potential of 90Y- and 131I-labeled anti-CD20 monoclonal antibody in treating non-Hodgkin's lymphoma with pulmonary involvement: a Monte Carlo-based dosimetric analysis.
    Song H; Du Y; Sgouros G; Prideaux A; Frey E; Wahl RL
    J Nucl Med; 2007 Jan; 48(1):150-7. PubMed ID: 17204712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radioembolization of hepatocarcinoma with (90)Y glass microspheres: development of an individualized treatment planning strategy based on dosimetry and radiobiology.
    Chiesa C; Mira M; Maccauro M; Spreafico C; Romito R; Morosi C; Camerini T; Carrara M; Pellizzari S; Negri A; Aliberti G; Sposito C; Bhoori S; Facciorusso A; Civelli E; Lanocita R; Padovano B; Migliorisi M; De Nile MC; Seregni E; Marchianò A; Crippa F; Mazzaferro V
    Eur J Nucl Med Mol Imaging; 2015 Oct; 42(11):1718-1738. PubMed ID: 26112387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Three-dimensional patient-specific dosimetry in radioimmunotherapy with 90Y-ibritumomab-tiuxetan.
    D'Arienzo M; Cicone F; Chiacchiararelli L; Coniglio A; Delaloye AB; Scopinaro F
    Cancer Biother Radiopharm; 2012 Mar; 27(2):124-33. PubMed ID: 22283680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.